{"id":"W2601149910","doi":"10.1200/jco.2012.30.15_suppl.10010","title":"Phase III, placebo-controlled trial (SUCCEED) evaluating ridaforolimus as maintenance therapy in advanced sarcoma patients following clinical benefit from prior standard cytotoxic chemotherapy: Long-term (≥ 24 months) overall survival results.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Vascular Tumors and Angiosarcomas","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; Clinical endpoint; Placebo; Adverse effect; Oncology; Population; Tolerability; Randomized controlled trial; Surgery; Confidence interval; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002308832,0.001662802,0.002664504,0.0004896937,0.0004970803,0.001054327,0.000916452,0.001889039,0.007442055],"category_scores_gemma":[0.001790464,0.0005183966,0.001814292,0.000470872,0.00120562,0.0008850932,0.0004048765,0.002921389,0.001363814],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007419098,"about_ca_system_score_gemma":0.001730641,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008002708,"about_ca_topic_score_gemma":0.001848744,"domain_scores_codex":[0.9994574,0.0002964628,0.00002790334,0.0001013561,0.00003419891,0.00008265272],"domain_scores_gemma":[0.9990176,0.0002354993,0.0002654804,0.0001016774,0.0000677779,0.0003119624],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9698972,0.007596528,0.0008376542,0.0006065815,0.000649013,0.00004718366,0.00004883287,0.0002355894,0.003693383,0.0001324668,0.001343563,0.01491197],"study_design_scores_gemma":[0.953566,0.04389274,0.00119868,0.0000232491,0.0001793074,0.00003396485,0.000008190363,0.0001558866,0.0002889703,0.00006601801,0.000581324,0.000005735993],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9667659,0.008973248,0.001438555,0.001343767,0.0007462373,0.01115799,0.003597569,0.0003995833,0.00557726],"genre_scores_gemma":[0.9682845,0.003394391,0.003464485,0.002593838,0.0007118635,0.01186331,0.00459152,0.0000526793,0.005043458],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007442055,"threshold_uncertainty_score":0.02489614,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08738783735493295,"score_gpt":0.4617867327801262,"score_spread":0.3743988954251932,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}